Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial
Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson, et al.
Laryngoscope Investigative Otolaryngology
|
February 16, 2024
Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland
Henry T Hoffman, Michael Koch, Robert Lee Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2021
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, et al.
Molecular Carcinogenesis
|
July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism
Brianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Cancer
|
May 6, 2021
Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients
William R Ryan, Mary J Xu, Edgar Ochoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC
Pablo Llerena, Hani Samarah, Kathryn Nunes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
November 3, 2020
Tracheostomy During the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries
Carol Bier-Laning, John D Cramer, Soham Roy, et al.
Laryngoscope Investigative Otolaryngology
|
September 25, 2025
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study
Mirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 14, 2023
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma
Mirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial
Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson, et al.
Laryngoscope Investigative Otolaryngology
|
February 16, 2024
Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland
Henry T Hoffman, Michael Koch, Robert Lee Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2021
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, et al.
Molecular Carcinogenesis
|
July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism
Brianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Cancer
|
May 6, 2021
Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients
William R Ryan, Mary J Xu, Edgar Ochoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC
Pablo Llerena, Hani Samarah, Kathryn Nunes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
November 3, 2020
Tracheostomy During the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries
Carol Bier-Laning, John D Cramer, Soham Roy, et al.
Laryngoscope Investigative Otolaryngology
|
September 25, 2025
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study
Mirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 14, 2023
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma
Mirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
Page
of 9